Jane Street’s Biotech Acquisition Company Warrant BIOTW Stock Holding History

Jane Street’s Portfolio BIOTW Stock Details BIOTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-52,649	Closed	-$3.36K	–	10527
2022 Q4	$3.36K	Hold	52,649	–	–	﹤0.01%	8899
2022 Q3	$3K	Hold	52,649	–	–	﹤0.01%	9507
2022 Q2	$5K	Buy	52,649 +338	+0.6%	+$70	﹤0.01%	9425
2022 Q1	$13K	Buy	52,311 +373	+0.7%	+$119	﹤0.01%	10032
2021 Q4	$34K	Buy	51,938 +1,938	+4%	+$1.34K	﹤0.01%	9667
2021 Q3	$33K	Sell	50,000 -887	-2%	-$660	﹤0.01%	9662
2021 Q2	$44K	Buy	50,887 +887	+2%	+$617	﹤0.01%	9533
2021 Q1	$30K	Buy	+50,000	New	+$35.3K	﹤0.01%	8932

Jane Street's BIOTW Position: Q1 2023 in Review

Jane Street sold out of Biotech Acquisition Company Warrant (BIOTW) in Q1 2023, closing a stake of 52,649 shares — an estimated $3.36K sold.

Jane Street first reported a position in BIOTW in Q1 2021 and held it in 8 quarters. The position peaked at $44K in Q2 2021. 0 funds tracked by Wall St. Rank hold BIOTW as of Q1 2023.

Jane Street reported no remaining Biotech Acquisition Company Warrant position as of Q1 2023 after selling out during the quarter.
Jane Street sold 52,649 Biotech Acquisition Company Warrant shares in Q1 2023, an estimated $3.36K.
Jane Street first reported a position in Biotech Acquisition Company Warrant in Q1 2021 and held it in 8 quarters.
Jane Street's Biotech Acquisition Company Warrant position peaked at $44K in Q2 2021.
0 funds tracked by Wall St. Rank held Biotech Acquisition Company Warrant as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.